直接口服抗凝剂用于急性静脉血栓栓塞症：画圆终成闭环？ - Suppr

Direct oral anticoagulants for acute venous thromboembolism: closing the circle?

作者信息

Verhamme Peter, Bounameaux Henri

机构信息

Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (P.V.); and the Department of Internal Medicine, University Hospitals of Geneva and Faculty of Medicine, Geneva, Switzerland (H.B.).

出版信息

Circulation. 2014 Feb 18;129(7):725-7. doi: 10.1161/CIRCULATIONAHA.113.007478. Epub 2013 Dec 16.

DOI:10.1161/CIRCULATIONAHA.113.007478

PMID:24344085

Abstract

摘要

相似文献

Direct oral anticoagulants for acute venous thromboembolism: closing the circle?

Circulation. 2014 Feb 18;129(7):725-7. doi: 10.1161/CIRCULATIONAHA.113.007478. Epub 2013 Dec 16.

Evidence suggests dabigatran is an effective and safe treatment for patients with VTE requiring early parenteral therapy.

Evid Based Med. 2014 Oct;19(5):180. doi: 10.1136/ebmed-2014-110008. Epub 2014 May 16.

Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.

Circulation. 2014 Feb 18;129(7):764-72. doi: 10.1161/CIRCULATIONAHA.113.004450. Epub 2013 Dec 16.

Management and outcomes of major bleeding during treatment with dabigatran or warfarin.

Circulation. 2013 Nov 19;128(21):2325-32. doi: 10.1161/CIRCULATIONAHA.113.002332. Epub 2013 Sep 30.

Dabigatran "non-inferior" to warfarin, but only just.

BMJ. 2013 Feb 27;346:f1219. doi: 10.1136/bmj.f1219.

Periprocedural dabigatran in atrial fibrillation ablation: a new kid on the block.

J Cardiovasc Electrophysiol. 2013 Aug;24(8):866-8. doi: 10.1111/jce.12168. Epub 2013 May 6.

Catheter ablation of atrial fibrillation: the need for studies to assess the efficacy and safety of novel anticoagulants.

J Interv Card Electrophysiol. 2013 Jan;36(1):3-4. doi: 10.1007/s10840-012-9720-3. Epub 2012 Sep 28.

New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome.

Am J Hematol. 2014 Oct;89(10):1017. doi: 10.1002/ajh.23797. Epub 2014 Sep 2.

Dabigatran has the upper hand on warfarin.

Thromb Haemost. 2013 Jul;110(1):4. doi: 10.1160/TH13-05-0362. Epub 2013 May 23.

Is there really misuse and abuse of dabigatran?

Med J Aust. 2013 Apr 15;198(7):358-9. doi: 10.5694/mja12.11642.

引用本文的文献

Impact of Age, Sex, and Renal Function on the Efficacy and Safety of Direct Oral Anticoagulants vs. Vitamin K Antagonists for the Treatment of Acute Venous Thromboembolism: A Meta-Analysis of 22,040 Patients.

Front Cardiovasc Med. 2021 Sep 8;8:700740. doi: 10.3389/fcvm.2021.700740. eCollection 2021.

Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE).

J Thromb Thrombolysis. 2021 Oct;52(3):863-871. doi: 10.1007/s11239-021-02415-5. Epub 2021 Mar 5.

Edoxaban Exposure-Response Analysis and Clinical Utility Index Assessment in Patients With Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism.

CPT Pharmacometrics Syst Pharmacol. 2016 Apr;5(4):222-32. doi: 10.1002/psp4.12077. Epub 2016 Apr 15.

Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis.

Acta Cardiol Sin. 2016 Jan;32(1):1-22. doi: 10.6515/acs20151228a.

Dental Procedures in Patients with Atrial Fibrillation and New Oral Anticoagulants.

Arrhythm Electrophysiol Rev. 2014 Aug;3(2):85-9. doi: 10.15420/aer.2014.3.2.85. Epub 2014 Aug 30.

Gene microarray analyses for potential biomarkers of single and recurrent venous thromboembolism.

Mol Med Rep. 2015 Nov;12(5):7358-66. doi: 10.3892/mmr.2015.4349. Epub 2015 Sep 22.

Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulants.

Thromb J. 2014 Oct 13;12:21. doi: 10.1186/1477-9560-12-21. eCollection 2014.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Direct oral anticoagulants for acute venous thromboembolism: closing the circle?

作者信息

Verhamme Peter, Bounameaux Henri

机构信息

Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium (P.V.); and the Department of Internal Medicine, University Hospitals of Geneva and Faculty of Medicine, Geneva, Switzerland (H.B.).

出版信息

Circulation. 2014 Feb 18;129(7):725-7. doi: 10.1161/CIRCULATIONAHA.113.007478. Epub 2013 Dec 16.

DOI:10.1161/CIRCULATIONAHA.113.007478

PMID:24344085

Abstract

摘要

相似文献

Direct oral anticoagulants for acute venous thromboembolism: closing the circle?

Circulation. 2014 Feb 18;129(7):725-7. doi: 10.1161/CIRCULATIONAHA.113.007478. Epub 2013 Dec 16.

Evidence suggests dabigatran is an effective and safe treatment for patients with VTE requiring early parenteral therapy.

Evid Based Med. 2014 Oct;19(5):180. doi: 10.1136/ebmed-2014-110008. Epub 2014 May 16.

Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.

Circulation. 2014 Feb 18;129(7):764-72. doi: 10.1161/CIRCULATIONAHA.113.004450. Epub 2013 Dec 16.

Management and outcomes of major bleeding during treatment with dabigatran or warfarin.

Circulation. 2013 Nov 19;128(21):2325-32. doi: 10.1161/CIRCULATIONAHA.113.002332. Epub 2013 Sep 30.

Dabigatran "non-inferior" to warfarin, but only just.

BMJ. 2013 Feb 27;346:f1219. doi: 10.1136/bmj.f1219.

Periprocedural dabigatran in atrial fibrillation ablation: a new kid on the block.

J Cardiovasc Electrophysiol. 2013 Aug;24(8):866-8. doi: 10.1111/jce.12168. Epub 2013 May 6.

Catheter ablation of atrial fibrillation: the need for studies to assess the efficacy and safety of novel anticoagulants.

J Interv Card Electrophysiol. 2013 Jan;36(1):3-4. doi: 10.1007/s10840-012-9720-3. Epub 2012 Sep 28.

New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome.

Am J Hematol. 2014 Oct;89(10):1017. doi: 10.1002/ajh.23797. Epub 2014 Sep 2.

Dabigatran has the upper hand on warfarin.

Thromb Haemost. 2013 Jul;110(1):4. doi: 10.1160/TH13-05-0362. Epub 2013 May 23.

Is there really misuse and abuse of dabigatran?

Med J Aust. 2013 Apr 15;198(7):358-9. doi: 10.5694/mja12.11642.

引用本文的文献

Front Cardiovasc Med. 2021 Sep 8;8:700740. doi: 10.3389/fcvm.2021.700740. eCollection 2021.

Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE).

J Thromb Thrombolysis. 2021 Oct;52(3):863-871. doi: 10.1007/s11239-021-02415-5. Epub 2021 Mar 5.

Edoxaban Exposure-Response Analysis and Clinical Utility Index Assessment in Patients With Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism.

CPT Pharmacometrics Syst Pharmacol. 2016 Apr;5(4):222-32. doi: 10.1002/psp4.12077. Epub 2016 Apr 15.

Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis.

Acta Cardiol Sin. 2016 Jan;32(1):1-22. doi: 10.6515/acs20151228a.

Dental Procedures in Patients with Atrial Fibrillation and New Oral Anticoagulants.

Arrhythm Electrophysiol Rev. 2014 Aug;3(2):85-9. doi: 10.15420/aer.2014.3.2.85. Epub 2014 Aug 30.

Gene microarray analyses for potential biomarkers of single and recurrent venous thromboembolism.

Mol Med Rep. 2015 Nov;12(5):7358-66. doi: 10.3892/mmr.2015.4349. Epub 2015 Sep 22.

Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulants.

Thromb J. 2014 Oct 13;12:21. doi: 10.1186/1477-9560-12-21. eCollection 2014.

Direct oral anticoagulants for acute venous thromboembolism: closing the circle?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Direct oral anticoagulants for acute venous thromboembolism: closing the circle?

作者信息

机构信息

出版信息

相似文献

引用本文的文献